Why a Multidisciplinary Team Approach in Managing Prostate Cancer Makes Sense

Abstract

Prostate cancer is among the most prevalent cancers in the developed world. It also remains one of the most complex diseases to treat. According to the American Cancer Society prostate cancer is a leading cause of cancer-related deaths.While the advent of PSA (prostate specific antigen) testing has shifted detection from late-stage disease to early-stage disease, it has also raised the challenge of distinguishing between fast-growing cancers that must be treated aggressively versus slow-growing cancers that may not become clinically significant in a patient's life. At the same time it gives us the option to detect clinically meaningful prostate cancers at a disease state that is most likely curable.